OPKOPKO Health, Inc.

$933M

Q1 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$545M+157.8% YoY

Gross Profit

$182M33.3% margin

Operating Income

$38M7.1% margin

Net Income

$31M5.7% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+10.2%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$823M

Stockholders' Equity

$1.7B

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$545M	$211M	+157.8%
Gross Profit	$182M	$71M	+155.1%
Operating Income	$38M	-$41M	+194.3%
Net Income	$31M	-$59M	+152.6%

Revenue Segments

Service

$507M93%

Product

$34M6%

Transfer of Intellectual Property and Other

$4M1%

Geographic Segments

UNITED STATES

$513M94%

CHILE

$14M3%

IRELAND

$7M1%

SPAIN

$6M1%

ISRAEL

$3M0%

MEXICO

$2M0%

Other Countries

$164,0000%

OPK Q1 2021 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena